Clinical Trial

An Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of North Star Desiccated Porcine Thyroid Extract Tablets.

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The North Star study is a multi-center, Phase 3, open-label, single-arm clinical study to evaluate the Efficacy and Safety of North Star therapy.
Trial Details
NCT Number NCT07747103
Lead Sponsor Neuvosyn Laboratories, LLC
Conditions Hypothyroidism
Enrollment 466 participants
Start Date 2026-06-30
Primary Completion 2027-11 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-05